Advertisement

Topics

Haemonetics GmbH Company Profile

14:08 EDT 26th September 2017 | BioPortfolio


News Articles [196 Associated News Articles listed on BioPortfolio]

Haemonetics Will Webcast Investor and Analyst Meeting

BRAINTREE, Mass., June 14, 2017 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) will webcast the management presentations and the question and answer period of its investor and analyst meetin...

Haemonetics to Present at Citi 2013 Global Healthcare Conference

BRAINTREE, Mass., Feb. 13, 2013 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced today that Brian Concannon, President & CEO, will present at the Citi 2013 Global Healthcare Conf...

Haemonetics to Present at Leerink Swann 2012 Global Healthcare Conference

BRAINTREE, Mass., Feb. 6, 2012 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced today that Chris Lindop, CFO and VP, Business Development, will present at the Leerink Swann ...

Haemonetics to Present at the Morgan Stanley Global Healthcare Conference

BRAINTREE, Mass., Aug. 26, 2013 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced today that Chris Lindop, CFO & EVP, Business Development, will present at the Morgan Stanley Glob...

FDA clears plasmapheresis system from Haemonetics

The FDA has granted Haemonetics 510(k) clearance for its NexSys PCS plasmapheresis system, intended for blood plasma collecti -More- 

Haemonetics Sets Date for Publishing 1st Quarter Fiscal 2018 Results: August 7, 2017

BRAINTREE, Mass., July 18, 2017 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced that the Company will publish first quarter fiscal 2018 financial results at 6:00am Eastern Time on M...

Haemonetics 1st Quarter Fiscal 2018 Earnings Release Available on Investor Relations Website

BRAINTREE, Mass., Aug. 7, 2017 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced that first quarter fiscal 2018 financial results are available on its Investor relations website. The...

Haemonetics Changes Timing of Fourth Quarter and Year End Fiscal Year 2012 Webcast: April 30, 2012 at 8:00 am Eastern Time

BRAINTREE, Mass., April 29, 2012 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced that it will conduct its April 30, 2012 webcast at 8:00 am (EDT), two hours earlier than previously ...

PubMed Articles [19 Associated PubMed Articles listed on BioPortfolio]

Safety and efficacy of incobotulinumtoxinA doses up to 800 U in limb spasticity: The TOWER study.

To evaluate safety (primary objective) and efficacy of increasing doses (400 U up to 800 U) of incobotulinumtoxinA (Xeomin, Merz Pharmaceuticals GmbH) for patients with limb spasticity.

Biomechanical Characterization of Subclinical Keratoconus Without Topographic or Tomographic Abnormalities.

To present a case series of patients with subclinical keratoconus with normal topometric (anterior curvature) and tomographic findings in one eye who showed abnormalities detected by Corvis ST (Oculus...

Pulled-out locking screw re-screwed spontaneously in anterior cervical decompression and fusion with the zero-profile implant system: A case report.

The zero-profile, standalone device (Zero-P, Synthes GmbH, Switzerland) has been reported to be an effective and safe treatment method with similar clinical outcomes compared with plate. Instrumental ...

Cyclic and Torsional Fatigue Resistance of Reciprocating Single Files Manufactured by Different Nickel-titanium Alloys.

The aim of this study was to evaluate the cyclic and torsional fatigue resistance of the following reciprocating single-file systems: ProDesign R 25.06 (Easy Equipamentos Odontológicos, Belo Horizont...

Reliability of a Skin Diagnostic Device in Assessing Hydration and Erythema.

To examine the reliability of a skin diagnostic device, the SD202 (Courage+Khazaka GmBH, Cologne, Germany), in assessing hydration and erythema of periwound skin and pressure injury-prone areas.

Clinical Trials [39 Associated Clinical Trials listed on BioPortfolio]

Bioequivalence Study Comparing Two Test Products With One Reference Product, All Containing 5 mg Yohimbine

- Type: Bioequivalence study in male healthy volunteers, therapeutical indication (erectile disfunction) not studied - Products, dosage, and route of administration: ...

Clinical Investigation to Evaluate the Haemonetics POLFA Modified Sample Needle Assembly With Vacuum Tube Holder

This study evaluates whether whole blood transferred through the new POLFA needle assembly meets supernatant hemoglobin acceptability standards.

Bioequivalence Study of Linagliptin From Prevaglip 5 mg Tablets(Eva Pharma, Egypt) and Trajenta 5 mg Tablets (Boehringer Ingelheim International GmbH, Germany)

An open label randomized, single dose, two-way crossover bioequivalence study to determine the bioequivalence of Linagliptin from Prevaglip 5 mg tablets(Eva pharma for Pharmaceuticals & Me...

User Performance Evaluation of Contour® Plus One, Accu-Chek® Performa Connect, FreeStyle Optium Neo and OneTouch® Select Plus Blood Glucose Monitoring Systems Following ISO 15197:2013; EN ISO 15197:2015

The user performance evaluation shows whether people with diabetes are able to obtain accurate measurement results with a blood glucose monitoring system. In this study, user performance e...

Telemedical Examination of a Three-Component Oculomotor Testing Battery

The study investigates the feasibility and safety of the telemedical implementation of three diagnostic oculomotor tests using a video-oculography device and an extended teleconferencing s...

Companies [522 Associated Companies listed on BioPortfolio]

Chemie-Kontor GmbH

Chemie-Kontor GmbH trades with chemical specialities for customers in Pharma-, Agro-, Cosmetics and Nutrition Industries and offers a broad range of services. Chemie-Kontor GmbH is agent for: Amberger...

OctreoPharm Sciences GmbH

OctreoPharm Sciences GmbH, located in Berlin (Germany) is a privately held clinical development company focusing on radiopharmaceuticals for the diagnosis and therapeutic control ...

Praher Beteiligungs GmbH

The vision of the company founder Ludwig Praher to produce better and better products of high-grade plastics was the basis for sound growth. Under the direction of Ing. Winfried Praher and Ewald Prahe...

Ormecon GmbH

Ormecon GmbH, with its location in Ammersbek/Germany, is the headquarter of Ormecon International. Ormecon GmbH was originally founded as "Ormecon Chemie GmbH & Co. KG" in 1996, as a 100% subsidiary o...

BioRegioN GmbH

BioRegioN GmbH is the successor to the BioRegioN initiative, and is the central point of contact for life science of the state of Lower Saxony. It provides specialist consultation on the life science ...

More Information about "Haemonetics GmbH" on BioPortfolio

We have published hundreds of Haemonetics GmbH news stories on BioPortfolio along with dozens of Haemonetics GmbH Clinical Trials and PubMed Articles about Haemonetics GmbH for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Haemonetics GmbH Companies in our database. You can also find out about relevant Haemonetics GmbH Drugs and Medications on this site too.

Quick Search
Advertisement
 

Corporate Database Quicklinks



Searches Linking to this Company Record